Accurate Wealth Management LLC raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 92.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,627 shares of the company's stock after buying an additional 1,746 shares during the quarter. Accurate Wealth Management LLC's holdings in Cardinal Health were worth $588,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. purchased a new stake in Cardinal Health during the 1st quarter valued at approximately $26,000. Jones Financial Companies Lllp boosted its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Tompkins Financial Corp boosted its position in shares of Cardinal Health by 106.7% during the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares during the last quarter. GW&K Investment Management LLC boosted its position in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after acquiring an additional 144 shares during the last quarter. Finally, NBC Securities Inc. bought a new position in shares of Cardinal Health during the 1st quarter valued at approximately $48,000. 87.17% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on CAH shares. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research report on Tuesday, August 12th. Wall Street Zen downgraded Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Leerink Partners lowered their target price on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research report on Tuesday, August 12th. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Argus set a $189.00 target price on Cardinal Health in a research report on Friday, August 22nd. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $165.93.
Read Our Latest Stock Report on Cardinal Health
Cardinal Health Stock Down 0.1%
Shares of CAH opened at $154.50 on Thursday. The company has a market cap of $36.71 billion, a PE ratio of 23.95, a P/E/G ratio of 1.31 and a beta of 0.73. The business has a fifty day moving average of $152.52 and a 200 day moving average of $148.91. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44.
Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period last year, the company earned $1.84 earnings per share. The business's revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is 31.63%.
Insider Buying and Selling at Cardinal Health
In other news, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares in the company, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by company insiders.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.